CDIB BIOSCIENCE VENTURES
CDIB BioScience Venture Management (CBVM) is a life science venture management company with operations in US and Taiwan. The majority of management team was spun-off from CDIB (China Development Industrial Bank) in 2001, one of the largest investment banks in Asia. CDIB remains to be a minor investor to the fund. The team has invested over 50 biotech companies globally in the past 10 years and majority of them successfully listed in global stock market exchanges or acquired.
CDIB BIOSCIENCE VENTURES
Social Links:
Founded:
2001-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Nginx Amazon CloudFront Google Adsense AWS Global Accelerator AdBlock Acceptable Ads Google Adsense For Domains
Similar Organizations
Forward Ventures
Forward Ventures ic a venture capital company that focuses in companies in the area of biological sciences.
PolyCore Therapeutics
PolyCore Therapeutics’ team of life sciences scientists is dedicated to developing breakthrough treatments for CNS Diseases.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2008-07-09 | ConforMIS | CDIB BioScience Ventures investment in Series D - ConforMIS | 14.92 M USD |
| 2008-02-20 | Ocera Therapeutics | CDIB BioScience Ventures investment in Series C - Ocera Therapeutics | 35.5 M USD |
| 2007-03-16 | Epiphany | CDIB BioScience Ventures investment in Series A - Epiphany | 36 M USD |
| 2007-01-08 | Proprius Pharmaceuticals | CDIB BioScience Ventures investment in Series A - Proprius Pharmaceuticals | 11 M USD |
| 2006-12-28 | Aprima Medical Software | CDIB BioScience Ventures investment in Series C - Aprima Medical Software | 6.8 M USD |
| 2006-12-01 | Xanthus Pharmaceuticals | CDIB BioScience Ventures investment in Series B - Xanthus Pharmaceuticals | 25 M USD |
| 2006-11-27 | Elixir Pharmaceuticals | CDIB BioScience Ventures investment in Series C - Elixir Pharmaceuticals | 31 M USD |
| 2005-11-09 | Nanosys | CDIB BioScience Ventures investment in Series C - Nanosys | 41.5 M USD |
| 2005-08-23 | Cerexa Inc. | CDIB BioScience Ventures investment in Series A - Cerexa Inc. | 50 M USD |
| 2005-06-06 | Somaxon Pharmaceuticals | CDIB BioScience Ventures investment in Series C - Somaxon Pharmaceuticals | 65 M USD |
More informations about "CDIB BioScience Ventures"
CDIB BioScience Venture Management investment portfolio
Dec 29, 2009 CDIB BioScience Venture Management was a life-science venture management firm, with operations in the United States and Taiwan. It preferred to invest in the life science …See details»
CDIB BioScience Venture Management - CB Insights
Jul 1, 2003 About CDIB BioScience Venture Management. CDIB BioScience Venture Management (CBVM) is a life science venture management company with operations in US …See details»
CDIB BioScience Ventures - Investments, Portfolio & Company Exits
CDIB BioScience Ventures has made 3 diversity investments. Their most recent diversity investment was on Jun 6, 2005, when Somaxon Pharmaceuticals raised. obfuscated. …See details»
CDIB BioScience Venture Fund I: Performance - PitchBook
May 31, 2007 CDIB BioScience Venture Fund I's latest investment was on 01-Sep-2015 in HenKan Pharmaceutical, a company within the Pharmaceuticals industry. Data Transparency. …See details»
CDIB Bioscience Venture Capital Profile | VentureDeal
CDIB BioScience Venture Management (CBVM) is a life-science venture management company, with operations in United States and Taiwan. CBVM was organized in December 2001 and …See details»
CDIB Bioscience Venture Management USA Inc - Bloomberg.com
Company profile page for CDIB Bioscience Venture Management USA Inc including stock price, company news, executives, board members, and contact informationSee details»
CDIB BioScience Ventures - Crunchbase
CDIB BioScience Venture Management (CBVM) is a life science venture management company with operations in US and Taiwan. Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Cdib Bioscience Venture Management Company Profile - Dun
Address: 10509 Vista Sorrento Pkwy Ste 201 San Diego, CA, 92121-2743 United StatesSee details»
CDIB BioScience Venture Management - BioCentury Company …
CDIB BioScience Venture Management - BioCentury Company Profiles for the biopharma industrySee details»
CDIB BioScience Venture Management Fund Manager Profile
CDIB BioScience Venture Management (CBVM) is a life science venture capital company, with offices in US and Taiwan. CBVM was established in 2001 as a spin-off of China Development …See details»
CDIB BioScience Venture Management - 15 Investments - Tracxn
CDIB BioScience Venture Management has made 15 investments across sectors such as Nanotechnology, Display Technology, Nanomaterial Displays and others. Ocera Therapeutics, …See details»
CDIB Bioscience - VC Firm Profile - Gaebler.com Venture Capital …
Venture Capital Investors CDIB Bioscience. venture capital fund CDIB Bioscience provides capital to innovative tech companies. Venture Investor OverviewSee details»
CDIB Ventures - CB Insights
May 1, 1998 About CDIB Ventures. The firm is a subsidiary of China Development Industrial Bank (CIDB) and was established to oversee CDIB's initial North American capital fund and to …See details»
CDIB BioScience Ventures - BioCentury Company Profiles - BCIQ
CDIB BioScience Ventures - BioCentury Company Profiles for the biopharma industrySee details»
CDIB BioScience Ventures - Tech Stack, Apps, Patents & Trademarks
CDIB BioScience Venture Management (CBVM) is a life science venture management company with operations in US and Taiwan.See details»
Home - Capra Biosciences
We use biology to make high performance renewable chemicals affordable and sustainable. We are revolutionizing chemical production with our patented bioreactor technology.See details»
Former Boston-based biotech firm set to debut new CT HQ
Mar 14, 2024 According to that annual report, the most recent available, the organization raised more than $2.6 million in 2022, with 95.7% spent on programs and 19 therapies in its …See details»
Novel Biotechnology - Crunchbase Company Profile & Funding
Novel Biotechnology may be growing as it has recently secured $2.5 million in seed round funding, which is a strong indicator of investor confidence and provides the capital necessary …See details»
Bioscience company to relocate headquarters, lab to Woodbridge
Sep 29, 2022 A clinical-stage nonprofit biotechnology company, Cure Rare Disease, has acquired its first laboratory space in Woodbridge. The organization will relocate its Boston …See details»